XM does not provide services to residents of the United States of America.
S
S

Sonova

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Top of the Street: Nestle, Anglo American, Bureau Veritas

BUZZ-Top of the Street: Nestle, Anglo American, Bureau Veritas A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** Deutsche Bank downgrades Nestle NESN.S to "hold" from "buy", saying the world's biggest packaged food company went "a cut too far" as it trimmed its sales growth outlook on Thursday ** UBS raises British miner Anglo American AAL.L to "buy" from "neutral" as it sees better risk/reward ratio after the stock fell enough following BHP's BHP.AX offer
B
B
N
S
A
M

Demant drops after profit warning

BUZZ-Demant drops after profit warning ** Shares in Demant DEMANT.CO fall around 10% to November lows after the Danish hearing aid maker cut its full-year outlook , citing a "significant" loss of market share for the managed care brand ** Demant now forecasts its organic revenue in 2024 to grow 2-4% against 4-8% seen earlier, expecting continuous low growth in the Hearing Aids unit ** It cuts adjusted EBIT guidance to 4.30-4.60 billion Danish crowns ($629-$672 million) from 4.60-5.00 billion cro
S
A

Swiss stocks - Factors to watch on June 13

Swiss stocks - Factors to watch on June 13 ZURICH/GDANSK, JUNE 13 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Thursday: LEM HOLDING LEHN.S LEM says CFO Andrea Borla to leave by end of November 2024 FLUGHAFEN ZUERICH FHZN.S Flughafen Zuerich May passengers up 9% at 2.8 mln ANALYSTS' VIEWS SFS GROUP AG SFSN.S - BAADER HELVEA CUTS TO ADD FROM BUY, RAISES TARGET PRICE TO CHF 134 FROM CHF 120 EX-DIVIDEND SONOVA SOON.S - 4.3000 CHF/shr dividend ECONOMY Swiss May produ
S
S

Ascential, Cellnex, Wise

EUROPE RESEARCH ROUNDUP- Ascential, Cellnex, Wise May 21 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Ascential, Cellnex and Wise on Tuesday. HIGHLIGHTS * Ascential ASCL.L : Berenberg re-initiates coverage with buy rating; target price 395p * Burberry BRBY.L : Barclays cuts target price to 1090p from 1340p * Cellnex CLNX.MC : Berenberg raises to buy from hold * Trainline TRNT.L : Deutsche Bank initiates coverage with buy rating a
3
B
B
B
B
B
B
C
C
C
C
D
E
E
F
H
H
L
N
R
S
S
S
S
U
B
E
I
P

Jefferies cuts Sonova to 'hold' on lack of short-term catalyst

BUZZ-Jefferies cuts Sonova to 'hold' on lack of short-term catalyst ** Jefferies cuts Sonova SOON.S to "hold" from "buy", citing short-term competition and low visibility ahead of new platform launch in H2 as well as weak FY results ** It cites a lack of a short-term catalyst for gains, saying the Swiss hearing aid maker's new platform launch is on
C
S
A

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.